Acute pancreatitis associated with interferon alpha therapy for chronic myelogenous leukemia

被引:8
|
作者
Tannir, NM [1 ]
Talpaz, M [1 ]
Ghazal, H [1 ]
Proothi, S [1 ]
Kantarjian, HM [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
关键词
acute pancreatitis; interferon alpha; CML;
D O I
10.3109/10428190009113396
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acute pancreatitis related to interferon alpha therapy is very rare. We report two patients with chronic myelogenous leukemia (CML) who developed acute pancreatitis following treatment with interferon alpha. A review of the literature on the association of pancreatitis and interferon alpha is provided. Possible pathophysiologic mechanisms are also discussed.
引用
收藏
页码:647 / 650
页数:4
相关论文
共 50 条
  • [31] ACUTE GOUT ASSOCIATED WITH CHRONIC MYELOGENOUS LEUKEMIA
    BLANTON, FM
    ANNALS OF INTERNAL MEDICINE, 1958, 48 (05) : 1118 - 1121
  • [32] Cost-effectiveness of interferon-alpha as maintenance therapy in chronic myelogenous leukemia - Response
    Kattan, MW
    Beck, JR
    ANNALS OF INTERNAL MEDICINE, 1997, 126 (08) : 664 - 665
  • [33] INTERFERON ALPHA-2B AS THERAPY FOR PATIENTS WITH PH'-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA
    ALIMENA, G
    MORRA, E
    LAZZARINO, M
    LIBERATI, AM
    MONTEFUSCO, E
    INVERARDI, D
    BERNASCONI, P
    MANCINI, M
    DONTI, E
    GRIGNANI, F
    BERNASCONI, C
    DIANZANI, F
    MANDELLI, F
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1990, 45 : 25 - 28
  • [34] INTERFERON-ALPHA THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA - QUESTIONS RELATED TO THE GERMAN RANDOMIZED TRIAL
    KANTARJIAN, HM
    TALPAZ, M
    BLOOD, 1995, 85 (10) : 2998 - 2999
  • [35] PROLONGED SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA AFTER CYTOGENETIC RESPONSE TO INTERFERON-ALPHA THERAPY
    KANTARJIAN, HM
    SMITH, TL
    OBRIEN, S
    BERAN, M
    PIERCE, S
    TALPAZ, M
    ROBERTSON, L
    KOLLER, C
    ESTEY, E
    KEATING, MJ
    ANNALS OF INTERNAL MEDICINE, 1995, 122 (04) : 254 - 261
  • [36] CHRONIC MYELOGENOUS LEUKEMIA - CELL-CULTURES AFTER THERAPY WITH ALPHA-INTERFERON - (CML)
    CASTAGNOLA, C
    BONFICHI, M
    MORRA, E
    BRERA, C
    BERNASCONI, P
    LAZZARINO, M
    BERNASCONI, C
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 782 - 782
  • [37] Nephrotic syndrome associated with alpha interferon therapy in chronic myeloid leukemia
    Akoglu, E
    CLINICAL NEPHROLOGY, 1997, 48 (01) : 59 - 60
  • [38] THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA WITH RECOMBINANT INTERFERON-GAMMA
    KURZROCK, R
    TALPAZ, M
    KANTARJIAN, H
    WALTERS, R
    SAKS, S
    TRUJILLO, JM
    GUTTERMAN, JU
    BLOOD, 1987, 70 (04) : 943 - 947
  • [39] INTERFERON-ALPHA IS AN ACTIVE THERAPEUTIC AGENT IN CHRONIC MYELOGENOUS LEUKEMIA
    KOYAMA, S
    SHIBATA, A
    ACTA HAEMATOLOGICA JAPONICA, 1990, 53 (08): : 1602 - 1610
  • [40] RESTORATION OF NONCLONAL HEMATOPOIESIS IN CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA
    EGERT, G
    KANZ, L
    LOHR, GW
    FAUSER, AA
    BLUT, 1990, 60 (05): : 282 - 286